Overview

Blueprint Biosecurity seeks to understand recent insights and advances pertaining to the ocular dosimetry of far-UVC. These insights aim to inform safety guidelines, technological innovation, and adoption strategies. Specific areas of interest include:

• Quantifying far-UVC dosimetry for human eyes:
  • Utilize modeling approaches
  • Employ contact lens dosimetry techniques
  • Leverage mannequins or comparable methodologies
• Highlighting recent advancements in experimental setups, measurement techniques, and data collection frameworks
• Developing technologies to accurately measure eye exposure to far-UVC doses in occupied zones, particularly in shared or high-traffic spaces

We encourage researchers and collaborators to share innovative methods and evidence-based results to drive forward the development of safe, effective far-UVC applications, primarily in the occupied zones of congregate spaces. 

Read the full Request for Information here.

Requested Information

In evaluating new approaches, Blueprint Biosecurity requests information on the following:

1. Quantifying how much far-UVC is reaching the eye using different lines of evidence – computational modeling, contact lens dosimetry, mannequins, etc.
2. Modeling eye far-UVC exposure under canonical and alternative built-environment device deployment.
3. Guidelines for updates to scientific methodology and reporting to increase study comparison.
4. Considerations and/or technology needed to advance field of study

Submissions

Who can submit: Blueprint Biosecurity welcomes responses from all sources and from anywhere in the world. This includes:

• academic students, staff, and faculty
• nonprofit or corporate employees
• volunteers and private individuals
• government or national lab personnel

Due Date: 5:00PM PDT on September 26, 2025

Instructions: 

• Responses should be submitted to ocular_RFI@blueprintbiosecurity.org.
• Submissions are encouraged, but not required, to follow the formatting requirements outlined here.

Questions can also be submitted to ocular_RFI@blueprintbiosecurity.org, and may be answered directly or added to a rolling FAQ.